Bicara Therapeutics

BCAX • XNAS

Bicara Therapeutics is a pharmaceutical preparations company trading on XNAS, led by CEO Claire Mazumdar Clemon, with a market cap of $1.2B.

CEOClaire Mazumdar Clemon

Market Cap$1.2B

PHARMACEUTICAL PREPARATIONS

Next Earnings

Upcoming earnings announcement for Bicara Therapeutics

Date

Tuesday, May 12, 2026 (in a month)

Timing

Before Market Open (6:00 AM New York)

Fiscal Period

Q1 2026

EPS Estimate

-$0.70

Past 5 earnings reports for Bicara Therapeutics

Date	Period	EPS	EPS Surprise	Revenue	Rev. Surprise	Filing
Nov 10, 2025	Q3 2025	-$0.67Est: -$0.54	-24.1%	-	—	10-Q
Aug 12, 2025	Q2 2025	-$0.50Est: -$0.54	+7.4%	-	—	10-Q
May 13, 2025	Q1 2025	-$0.68Est: -$0.38	-78.9%	-	—	10-Q
Mar 27, 2025	Q4 2024	-$0.39Est: -$0.29	-34.5%	-	—	10-K
Nov 12, 2024	Q3 2024	-$1.60	—	-	—	10-Q